Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2025-12-17 Regulatory Filings
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 1% confidence The document is a formal announcement regarding an upcoming 'Corporate Presentation' (IR) event. It provides details such as the date, time, location, purpose (clinical trial results), and contact information. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a general regulatory filing/announcement.
2025-12-17 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2025-10-27 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Raphas' (주식회사 라파스) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
[기재정정]반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Raphas' (주식회사 라파스) for the period ending June 30, 2025. It contains detailed financial data, business descriptions, management discussions, and capital structure information. According to the definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) containing actual financial statements and analysis is classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-14 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a South Korean company (Raphas) regarding the acquisition of its own convertible bonds before maturity (Put Option exercise). This type of filing relates to capital structure changes and debt management. According to the provided definitions, 'CAP' (Capital/Financing Update) is the most appropriate category for updates on financing activities and capital structure changes, including bond repurchases.
2025-07-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Do Young-hun) of Raphas. This is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in share ownership by company directors and executives. This corresponds to the 'Director's Dealing' category.
2025-06-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.